ESMO Media Releases

Researchers have explored the analysis of mutations in cerebrospinal fluid of lung cancer patients with brain metastases in a study presented at the ESMO Asia 2017 Congress. 

The European Society for Medical Oncology (ESMO) opened its 3^rd ESMO Asia Congress today, once again in Singapore, attracting close to 3000 regional and international cancer doctors with leading researchers and experts to promote advances in science, diagnosis, treatment, and best practices for cancer patients in Asia

ESMO Asia 2017 Congress reveals the psychosocial impact on cancer survivors in Asia and their unmet needs. 

ESMO, the leading professional organisation for medical oncology, is pleased to announce the publication of the ESMO Precision Medicine Glossary in the Annals of Oncology.

The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, is pleased to announce the third ESMO Asia 2017 Congress. 

ESMO, the leading professional organisation for medical oncology, is pleased to announce the ESMO Asia 2017 Congress, which will be held 17 to 19 November at the Suntec Singapore Convention and Exhibition Centre.

ESMO President, Fortunato Ciardiello, has contributed an editorial on the priorities for future cancer research, to The Lancet Oncology with Josep Tabernero, ESMO President-Elect as co-author.

ESMO, the leading European professional organisation for medical oncology, was present at the WHO Global Conference on Noncommunicable Diseases (NCDs*) that finished last Friday in Montevideo, Uruguay.

Men who smoke and have five or more partners with whom they perform oral sex have the highest risk of developing a type of head and neck cancer that is triggered by exposure to the human papilloma virus – known as HPV-related oropharyngeal cancer – according to research published in the leading cancer journal Annals of Oncology [1] today (Friday).

Cancer outcome depends on complex interactions between many mutations, experts highlighted at the Molecular Analysis for Personalised therapy (MAP) Congress, held 13-14 October in Zurich, Switzerland.

ESMO has granted the newly established ESMO Award in Immuno-Oncology to honour individuals for their outstanding achievements in the field.

ESMO, the leading European professional organisation for medical oncology announced today that Professor Fabrice André, MD, PhD, will be the new interim Editor-in-Chief of Annals of Oncology as of 14 September 2017.